NDC 83021-551

AnubisMed

Spf 50 Broad Spectrum Protection Fluid Emulsion

AnubisMed is a Topical Cream in the Human Otc Drug category. It is labeled and distributed by Anubis Cosmetics Sl. The primary component is .alpha.-tocopherol; Anhydrous Citric Acid; Ascorbic Acid; Ascorbyl Palmitate; Avobenzone; Bemotrizinol; Butylated Hydroxytoluene; Butylene Glycol; C20-22 Alcohols; Carbomer Copolymer Type A (allyl Pentaerythritol Crosslinked); Carbomer Homopolymer, Unspecified Type; Chlorphenesin; Dimethicone; Fragrance 13576; Glycerin; Linoleic Acid; Linolenic Acid; Octinoxate; Octisalate; Octocrylene; Phenoxyethanol; Poly(methyl Methacrylate; 450000 Mw); Polyethylene Glycol 400; Propylene Glycol; Silicon Dioxide; Titanium Dioxide; Tromethamine; Water.

Product ID83021-551_e99d92c4-8769-9c0a-e053-2a95a90a609e
NDC83021-551
Product TypeHuman Otc Drug
Proprietary NameAnubisMed
Generic NameSpf 50 Broad Spectrum Protection Fluid Emulsion
Dosage FormCream
Route of AdministrationTOPICAL
Marketing Start Date2022-10-15
Marketing CategoryOTC MONOGRAPH FINAL /
Application NumberM020
Labeler NameANUBIS COSMETICS SL
Substance Name.ALPHA.-TOCOPHEROL; ANHYDROUS CITRIC ACID; ASCORBIC ACID; ASCORBYL PALMITATE; AVOBENZONE; BEMOTRIZINOL; BUTYLATED HYDROXYTOLUENE; BUTYLENE GLYCOL; C20-22 ALCOHOLS; CARBOMER COPOLYMER TYPE A (ALLYL PENTAERYTHRITOL CROSSLINKED); CARBOMER HOMOPOLYMER, UNSPECIFIED TYPE; CHLORPHENESIN; DIMETHICONE; FRAGRANCE 13576; GLYCERIN; LINOLEIC ACID; LINOLENIC ACID; OCTINOXATE; OCTISALATE; OCTOCRYLENE; PHENOXYETHANOL; POLY(METHYL METHACRYLATE; 450000 MW); POLYETHYLENE GLYCOL 400; PROPYLENE GLYCOL; SILICON DIOXIDE; TITANIUM DIOXIDE; TROMETHAMINE; WATER
Active Ingredient Strength0 g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; g/50mL; mL/50mL
Pharm ClassesAcidifying Activity [MoA], Allergens [CS], Anti-coagulant [EPC], Ascorbic Acid [CS], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Decreased Coagulation Factor Activity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC], Skin Barrier Activity [PE], Vitamin C [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 83021-551-50

50 mL in 1 BOTTLE (83021-551-50)
Marketing Start Date2022-10-15
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "AnubisMed" or generic name "Spf 50 Broad Spectrum Protection Fluid Emulsion"

NDCBrand NameGeneric Name
83021-400AnubisMedSodium Bicarbonate, Aloe Barbadensis Leaf Juice, Imidazolidinyl Urea
83021-401AnubisMedGlycolic Acid, Citric Acid, Lactic Acid, Kojic Acid
83021-402AnubisMedAzelaic Acid, Salicylic Acid
83021-551AnubisMedSPF 50 Broad Spectrum Protection Fluid Emulsion
83021-750ANUBISMEDHA HYALURONIC
83021-774AnubisMedAloe Barbadensis Leaf Extract, Propylene Glycol, Cetearyl Ethylhexanoate

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.